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Ureteric bud (UB) is the embryonic kidney progenitor tissue that gives rise to the collecting duct and lower
urinary tract. UB-like structures generated from human pluripotent stem cells by previously reported
methods show limited developmental ability and limited branching. Here we report a method to generate
UB organoids that possess epithelial polarity and tubular lumen and repeat branching morphogenesis. We
also succeed in monitoring UB tip cells by utilizing the ability of tip cells to uptake very-low-density lipopro-
tein, cryopreserving UB progenitor cells, and expanding UB tip cells that can reconstitute the organoids and
differentiate into collecting duct progenitors. Moreover, we successfully reproduce some phenotypes ofmul-
ticystic dysplastic kidney (MCDK) using the UB organoids. These methods will help elucidate the develop-
mental mechanisms of UB branching and develop a selective differentiation method for collecting duct cells,
contributing to the creation of disease models for congenital renal abnormalities.
INTRODUCTION
The mammalian adult kidney, metanephros, develops by the
reciprocal interaction between two embryonic progenitor tis-
sues, metanephric mesenchyme and ureteric bud (UB) (Costan-
tini and Kopan, 2010). UB has epithelial polarity and tubular
lumen (Meyer et al., 2004) and consists of two domains, the tip
and trunk. The tip cells produce both new tip and trunk cells
that further differentiate into collecting ducts (CDs). Nephron
progenitors (NPs) included in metanephric mesenchyme secrete
glial cell-derived neurotrophic factor (GDNF) to maintain the pro-
liferation and regulate the branching morphogenesis of UB cells
and also undergo a mesenchymal-to-epithelial transition to form
nephron structures (Costantini and Kopan, 2010; Takahashi,
2001).
Congenital anomalies of the kidney and urinary tract (CAKUT)
describe a group of disorders that result from the developmental
abnormalities of CD lineage cells, such as multicystic dysplastic
kidney (MCDK) (Yosypiv, 2012). In addition to conventional
experimental animal models, the creation of in vitro disease
models using human cells for CAKUT can provide powerful
research tools for pathological analyses and the development
of novel therapies. Indeed, a recent study generated patient-
specific human induced pluripotent stem cells (hiPSCs) from
small volumes of urine from pediatric CAKUT patients and differ-
entiated them into kidney organoids, showing the use of urine as
a reliable source of hiPSCs from CAKUT patients (Mulder et al.,
2020). In order to extend the findings and generate disease
models for many CAKUT forms, the establishment of selective
differentiation and expansion culture methods for CD lineage
cells derived from hiPSCs and human embryonic stem cells
(hESCs) is required.
Recently, we reported a stepwise protocol to induce hiPSCs/
ESCs into UB-like structures through anterior intermediate
mesoderm (Mae et al., 2013, 2018). However, the generation of
hiPSC/ESC-derived UB-like tissues that show tubular lumens
or sufficient branching have not been achieved (Mae et al.,
2018; Taguchi and Nishinakamura, 2017; Xia et al., 2013).
In the present study, we established a method to induce
hiPSCs to differentiate into UB organoids with epithelial polarity
and tubular lumens that repeat branching morphogenesis. The
isolated tip regions from the UB organoids showed repeated
branching to reconstitute the UB organoids. We also succeeded
in establishing in vitromonitoring and expansion methods for tip
cells that could efficiently reconstitute UB organoids and differ-
entiate into CD progenitors (CDPs). Finally, we developed a dis-
ease model for MCDK using the UB organoids.
RESULTS
Generation of UB Organoids that Have Tubular Lumens
and Show Repeated Branching Morphogenesis
We first modified our previously reported nephric duct (ND) in-
duction method by adding a retinoic acid (RA) agonist, 4-[(E)-2-
(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-pro-
penyl]-benzoic acid (TTNPB), to stage 4, because RA signals
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play crucial roles in ND development (Stewart and Bouchard,
2014) (Table S1). We also found that prolonged treatment with
the ND elongation factors used at stage 4 induced the epithe-
lialization of ND cells (data not shown). Therefore, we gener-
ated ND epithelial aggregates at stage 5 by using the same
inducing factors as stage 4 and removed unwanted cells by
pipetting (Figure S1A). Importantly, we found that ND leading
edge cells at stage 4 can be stocked with a commercially
available cryopreservation reagent. The stocked cells main-
tain the potential to form ND epithelial aggregates to the
same extent as non-cryopreserved ND leading edge cells
(Figures S1B and S1C). We thus used these cryopreserved
cells in most of the following examinations. The addition of
low concentrations of Matrigel to the culture media was re-
ported to promote the formation of apicobasal polarity in inner
ear organoids (Koehler et al., 2017). Accordingly, we added a
low concentration (2%) of Matrigel to our ND aggregates at
stage 6, which effectively induced UB (iUB)-like structures
Figure 1. iUB Organoids Have Tubular Lu-
mens and Show Repeated Branching
Morphogenesis
(A) Morphology of stage 6 day 7 aggregates
cultured with high (50%, left panel) and low (2%,
right panel) concentrations of Matrigel.
(B) Immunostaining of a day 6 iUB organoid for
PAX2 (green), EZRIN (red), and LAMININ (purple).
(C) Morphological changes of a tip separated from
a day 6 iUB organoid for 7 days.
(D) Immunostaining of a day 14 tip-derived orga-
noid for PAX2 (blue), RET (green), and CK8 (red).
(E and F) Immunostaining of a day 6 iUB organoid
cultured in organoid medium for RET (red) and
GATA3 (green) (E), and for LAMININ (green), EZRIN
(white), and PAX2 (red) (F).
(G) A UMAP plot exhibiting nine clusters in iUB
organoid.
(H) Pseudo-time trajectory using Monocle2.
(I) A heatmap showing the expression pattern of
UB markers, HIF1a downstream genes, VEGFA
and NOTCH1, and cell proliferative markers,
MKI67 and TOP2A, along the pseudo-time axis.
All data were obtained from cryopreserved UB
progenitors. Scale bars, 100 mm.
(Figures 1A and S1D). Unlike our previ-
ous UB-like structures, immunostaining
showed that the current ones expressed
not only a basal marker, LAMININ, but
also an apical marker, EZRIN, indicating
that these structures have apicobasal
polarity and tubular lumens, in addition
to the formation of RET+ tip and CK8+
trunk domains (Figures 1B and S1E–
S1H). The presence of tubular lumens
was also shown by toluidine blue stain-
ing of the current UB-like structures
(Figure S1I). Thus, we induced UB struc-
tures with tip/trunk domains, epithelial
polarity, and tubular lumens, and here-
after call these structures iUB organoids. We then manually
separated the tips from the iUB organoids and cultured
them in stage 6 medium (Figures S2A and S2B). The sepa-
rated tips formed branching structures with tip and trunk
regions and epithelial polarity similar to the original iUB orga-
noids, suggesting the reconstitution of iUB organoids (Figures
1C, 1D, and S2C). Moreover, the tips separated from the re-
constituted iUB organoids also reconstituted iUB organoids
with branching morphogenesis. This reconstitution process
could be repeated 3–4 times for each tip, and each tip could
branch 4–5 times, meaning one tip could branch maximally 20
times (Figure S2D). Furthermore, we found that adding
epidermal growth factor (EGF) and fibroblast growth factor 1
(FGF1) to stage 6 medium (hereafter called organoid medium)
promoted budding with tip and trunk structures and epithelial
polarity (Figures 1E, 1F, and S2E–S2G; Table S1).
Next, we performed single-cell RNA sequencing (scRNA-seq)
to dissect cell types in the iUB organoid and conducted
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dimensionality reduction to cluster cells with similar gene expres-
sion profiles using Uniform Manifold Approximation and Projec-
tion (UMAP). We found that GATA3-expressing cell aggregate
(clusters 0, 1, 2, 3, and 6) (Figures 1G and S3A) exhibited a heter-
ogenous expression of RET, WNT11, ETV5, and KRT19 among
clusters (Figures S3B and S3C). Thus, we assumed that cells in
clusters 0, 2, and 6 with RET expression were located on the
tips of iUB organoid, while the trunk consisted of cells in clusters
1 and 3withKRT19 expression. Additionally, we found that iUBor-
ganoid contained off-target cells that resembleMEIS2-expressing
peri-UB mesenchyme-like cells (clusters 4 and 5) and SOX2-ex-
pressing neural cells (cluster 8) (Figure S3D). Comparative expres-
sion analysis showed that hypoxia inducible factor 1a (HIF-1a)-
induced genes, including VEGFA andNOTCH1, were upregulated
in trunk cells (Table S2), whereas tip cells highly but differentially
expressed the cell proliferation markers MKI67 and TOP2A (Fig-
ure S3D). We also found HOX family genes were differentially ex-
pressed between the tip and trunk clusters (Figure S3E). However,
a previous study reported no segmental specificity of Hox gene
expression in developing mouse UBs based on in situ hybridiza-
tion (Patterson and Potter, 2004). Future studies should examine
whether segmental regulation is involved in iUB formation. We
then addressed transcriptional dynamics during iUB organoid for-
mation by trajectory analysis using Monocle2. As with the UMAP,
cells were roughly lined up in the order of clusters 6, 2, 0, 1, and 3
(Figure 1H). In the pseudo-time axis, cells on the left side were tip
cells expressing RET and ETV5, whereas cells on the right side
were trunk cells with high expression of KRT8 and KRT19, as
well asVEGFA andNOTCH1 (Figure 1I). Interestingly,RET expres-
sion was broadly increased on the left side compared with the
right side. However, the peak expression was not at the very left
edge but a little before there, whereas the highest expression of
MKI67 and TOP2A was observed at the very left edge (Figure 1I),
indicating that cells at the left edge were proliferating tip cells.
These results are consistent with previous in vivo findings that
Ret expression is dominant at the broad tip rather than distal tip
(Rutledge et al., 2017), and that tip cells act as proliferative stem
cells in the mouse UB branching process (Shakya et al., 2005).
We therefore successfully generated iUB organoids with epithelial
polarity and tubular lumens consisting of distinct tip and trunk
cells, and show the developmental potential to repeat branching
morphogenesis.
Monitoring and Expansion Culture of Tip Cells
We next found that dissociated single iUB cells successfully
expanded to form colonies on soft hydrogel that resembled tip
regions expressing RET and GATA3 (Figures 2A–2C). To reveal
the origin of the tip colonies, we attempted to develop methods
to monitor tip cell development. Consistent with a previous
report, we found that very-low-density lipoprotein (VLDL) recep-
tor is expressed at the tip regions by immunostaining analysis
(Rutledge et al., 2017) (Figure S4A). We also confirmed that
whole tip colonies and tip regions of iUB organoids, but not ND
aggregates, imported VLDL conjugated with 1,1’-Dioctadecyl-
3,3,3’,3’-Tetramethylindocarbocyanine Perchlorate (DiI) (DiI-
VLDL) (Figure 2D). Additionally, RNA-seq comparing DiI+ and
DiI cells purified by flow cytometry indicated the upregulated
expression of tip-related genes in DiI+ cells, but the expression
of trunk-related genes was higher in DiI cells (Figure 2E). This
monitoring technique clarified that the percentage of DiI+ tip cells
increased from 54.0% ± 2.1% to 91.8% ± 2.8% after 7 days by
our hydrogel culture (n = 3; Figure 2F). Interestingly, tip colonies
importing DiI-VLDLwere derived from not only DiI+ cells, but also
DiI cells after 7 days (Figure 2G). The percentage of tip cells
derived from DiI cells was high at 80.5% ± 1.6%, although
significantly lower than that derived from DiI+ cells (88.9% ±
0.5%; Figure 2H). These results are consistent with the previous
finding that UB trunk cells can regenerate tip cells in vitro (Yuri
et al., 2017).
In order to establish a robust reconstitution method of iUB or-
ganoids from tip colonies, we focused on the Wnt signaling
pathway and replaced CHIR99021 with Wnt3a conditionedme-
dium and R-spondin1 in organoid medium (hereafter called
modified medium). Consequently, we found that branching
iUB organoids with tip and trunk regions and epithelial polarity
could be reconstituted from tip colonies with modified medium
(Figures 2I–2K). Importantly, iUB organoids could be reconsti-
tuted from not only DiI+ tip single cells, but also DiI trunk single
cells (Figures 2L and 2M). Moreover, we found that tip regions
separated from iUB organoids derived from single iUB cells
via tip colonies reconstituted iUB organoids, demonstrating
the establishment of a simplified expansion method of tip cells
with the developmental potential to form iUB organoids (Fig-
ure S4B). To elucidate the developmental mechanism of iUB or-
ganoid reconstitution from tip colonies, we added a Notch
Figure 2. Monitoring and Expansion Methods for Tip Cells
(A) A schematic showing the formation of tip colonies from single iUB cells on hydrogel.
(B) Morphological changes of single iUB cells dissociated from iUB organoids for 7 days.
(C) Immunostaining of a day 7 tip colony for RET (green) and GATA3 (red).
(D) Bright-field and fluorescence microscopy images of tip colonies, a ND aggregate, and an iUB organoid after DiI-VLDL uptake.
(E) A heatmap showing differentially expressed genes between DiI+ and DiI cells evaluated by RNA-seq.
(F) The percentage of DiI+ cells in day 7 iUB organoids and day 7 tip colonies.
(G) Fluorescence microscopy analysis of DiI and DiI+ cells on days 0 and 7.
(H) The percentage of DiI+ cells in day 6 tip colonies derived from single DiI+ and DiI cells.
(I) Morphology of day 7 iUB organoids reconstituted from tip colonies in organoid medium containing CHIR99021 or Wnt3a.
(J) Morphology of a day 18 iUB organoid reconstituted from a tip colony in modified medium.
(K) Immunostaining of a day 18 reconstituted iUB organoid for EZRIN (green) and LAMININ (red) (left panel) and for RET (green), GATA3 (red), and nuclei (blue)
(right panel).
(L) Morphology of day 7 tip colonies derived from DiI (left panel) and DiI+ (right panel) single iUB cells.
(M) Morphology of day 16 iUB organoids reconstituted from tip colonies derived from DiI (left panel) and DiI+ (right panel) single iUB cells.
All data were obtained from cryopreserved UB progenitors. *p < 0.05, **p < 0.001, by Student’s t test in (F) and (H). Scale bars, 100 mm.





phenylglycine tert.butyl ester] (DAPT), to modified medium ac-
cording to the scRNA-seq data (Figure 1I). The resultant inhibi-
tion of budding structure formation by DAPT treatment indi-
cated that Notch signaling is involved in iUB formation
(Figure S4C).
Induction of CDPs
BecauseWnt/b-catenin signals maintain stem cells in UB tip re-
gions (Yuri et al., 2017), we retrieved tip colonies from the hy-
drogel and cultured them using a WNT signal inhibitor, IWR-1
(Figure 3A). IWR-1 treatment facilitated the differentiation of
dissociated tip cells into cells expressing a CD principal cell
Figure 3. Induction of CDPs
(A) A schematic showing the induction methods of CDPs.
(B) Immunostaining of dissociated tip colony cells on day 7 in 2D culture with or without A83-01 for GATA3 (green), AQP2 (red), and nuclei (blue).
(C) Immunostaining of dissociated tip colony cells on day 7 in 2D culture for AQP2 (red), E-CADHERIN (white), nuclei (blue), and FOXA1 (green).
(D) A heatmap showing differentially expressed genes between CDPs and tip colony (TIP) cells evaluated by RNA-seq.
(E) The top 5 Gene Ontology biological processes for the significantly differentially expressed (p < 0.05) genes between CDPs and TIP cells.
(F and G)Morphology (F) and immunostaining images of day 28 CDP-like tubular structures derived from a day 14 reconstituted iUB organoid from a tip colony for
FOXA1 (white), AQP2 (red), and GATA3 (green) (G).
All data were obtained from cryopreserved UB progenitors. Scale bars, 100 mm.




marker, Aquaporin 2 (AQP2) (Figure 3B). We also found that
combination treatment with IWR-1 and a TGFb signal inhibitor,
A83-01, more efficiently generated AQP2+ cells (Figure 3B).
These cells also expressed a trunk-specific marker, FOXA1,
but not an intercalated cell marker, carbonic anhydrase (CA)
II, suggesting the development of CDPs (Figures 3C and
S4D). RNA-seq indicated that some marker genes for CD prin-
cipal cells, such as AQP2 and FOXA1, are expressed in CDPs;
however, neither other principal cell markers, AQP3 and AQP4,
nor intercalated cell markers, FOXI1 and V-type proton ATPase
subunit B, kidney isoform (ATP6V1B1), were expressed (Fig-
ures 3D, S4E, and S4F). Gene Ontology (GO) analysis also
showed relevant biological processes for tip colonies and
CDPs (Figure 3E). Specifically, cell proliferation-related genes
were upregulated in tip colonies, while extracellular matrix
and receptor-related genes were expressed in CDPs. Thus,
these induced CDPs may correspond to around gestational
week (GW) 7 CDPs, which express only principal cell markers
(Wang et al., 2018). Moreover, we found that the same two-fac-
tor treatment differentiated reconstituted iUB organoids
derived from tip colonies into AQP2+ CDP-like tubular struc-
tures (Figures 3F and 3G).
Generation of an MCDK Disease Model Using HNF1b+/
iUB Organoids
Finally, we attempted to establish a CAKUT disease model using
our current iUB organoid technique. The mutations of a UB line-
age marker, HNF1b, are associated with renal hypoplasia and
MCDK (Bellanne´-Chantelot et al., 2004; Heidet et al., 2010; Na-
kayama et al., 2010). A mouse model with CD-specific deletion
of Hnf1b showed the abnormalities of ductal apicobasal polarity
(Desgrange et al., 2017; De Vas et al., 2015). We thus established
a heterozygous HNF1b-knockout (HNF1b+/) hiPSC line by the
CRISPR-Cas9 system (Figure 4A). Although this cell line could
be differentiated into iUB organoids, these organoids were
phenotypically different from wild-type (WT) iUB organoids in
that the number of budding regions tends to be reduced (Fig-
ure 4B). Immunostaining showed that RET+ tip regions in
HNF1b+/ iUB organoids were smaller than those in WTs (Fig-
ure 4C), and that apicobasal polarity was lost in HNF1b+/ iUB
organoids, as evidenced by the reduced expression of apical
markers, PRKCz and EZRIN (Figures 4D and S4G). Additionally,
we confirmed that the expressions of PRKCz and EZRIN (relative
expressions compared with WT were 0.61 ± 0.18, p = 0.021, and
0.75 ± 0.11, p = 0.016, respectively), and UB lineage markers
downstream of HNF1b, LHX1, and PAX2 (relative expressions
compared with WT were 0.32 ± 0.28, p = 0.014, and 0.44 ±
0.21, p = 0.010, respectively), were significantly decreased in
HNF1b+/ iUB organoids (Figure 4E). The expressions of other
HNF1b downstream markers, RET and WNT11, tended to
decrease in HNF1b+/ iUB organoids compared with WT,
although the difference was not statistically significant (relative
expressions compared with WT were 0.62 ± 0.35, p = 0.138,
and 0.49 ± 0.36, p = 0.07, respectively) (Figure S4H). These find-
ings are similar to those found in a MCDK model mouse (Lok-
mane et al., 2010; Desgrange et al., 2017), indicating that our
iUB organoids can be used to develop disease models for one
form of CAKUT.
DISCUSSION
PreviouslygeneratedUB lineagecells fromhiPSCs/ESCshave lim-
itations. Takasato et al. (2015) reported that the GATA3+ECAD-
HERIN+ cells contained in their kidney organoids are UB lineage.
However, their organoids lacked branching UB structures, and
scRNA-seq of the organoids indicated that these cells could be
distal tubules or connecting segments, which also express
GATA3 and E-CADHERIN, derived from NPs (Combes et al.,
2019; Lindstro¨m et al., 2018b). Additionally, although Taguchi
and Nishinakamura, 2017 inducedUB-like structures from hiPSCs
that express SOX9 and CK8 based on quantitative real-time PCR
(qRT-PCR) and immunostaining analyses, these markers are not
specific to UB lineages. Thus, the generation of UB tissues with
distinct tip and trunk regions from hiPSCs/ESCs has not been fully
demonstrated. Importantly, we have demonstrated in the current
study that our iUB organoids recapitulate in vivo development
accompanied by spatiotemporal regulation of the gene network
by high-resolution transcriptomeanalysis using scRNA-seq,which
showed the reciprocal expression of UB tip and trunk markers.
Although the hypoxic activation of HIF increases paracrine
vascular endothelial growth factor A (VEGFA) signaling to
enhance UB branching (Schley et al., 2015), the developmental
significance and role of the signaling in the UB trunk are unclear.
During kidney development, the blood vessels first arise to form
a vascular ring around the UB trunk (Munro et al., 2017). It was
also reported that the branching pancreatic bud recruits blood
vessels via VEGFA to enhance trunk cell maintenance and inhibit
acinar cell differentiation (Cleaver and Dor, 2012). These find-
ings, including ours, suggest that VEGFA secretion from the
UB trunk may support vascular network formation in kidney
development. Further studies are needed to reveal the precise
interaction between hypoxia-responsive molecules and renal
vascular formation.
It takes about 2 weeks to generate our iUB organoids from
hiPSCs. This time might reflect an in vivo developmental clock,
because hiPSCs are equivalent to embryonic days 6–14 (Naka-
mura et al., 2016) and metanephric kidney development begins
at GW4 in humans (Lindstro¨m et al., 2018). In addition, a recent
study reported that human CDPs expressing AQP2, but not CAII,
appear at GW7 (Wang et al., 2018). This time course also coin-
cides with our induction protocol, in which it takes about 5weeks
to differentiate AQP2+CAII progenitors from hiPSCs. Although
one valuable approach to inducing AQP2+ cells is a co-culture
that forms aggregates from hiPSC-derived UB cells and NPs
(Tsujimoto et al., 2020), the selective induction of CDPs from
iUB organoid-derived expanded tip colonies established in this
study without co-cultures is notably advantageous.
However, there are limitations in the current study as well. First,
although we examined various co-culture conditions with iUB or-
ganoids and hiPSC-derived NPs, extensive UB branching
morphogenesis was not achieved even though NPs differentiated
into nephron structures (data not shown). One possible explana-
tion is that, although interstitial cells are required for the inductive
branching morphogenesis of UB by reciprocal interactions with
NPs in mouse ESC differentiation culture (Taguchi and Nishinaka-
mura, 2017), our co-culture conditions may contain no interstitial
cells. Another possibility is a discrepancy in the time required for




Figure 4. Generation of an MCDK Disease Model
(A) A part of the nucleotide sequence of HNF1b exon 1 and the guide RNA (gRNA) target region. An HNF1b+/ hiPSC line was established by a single-base (red)
insertion.
(B) Morphological changes of ND aggregates derived from wild-type (WT) and HNF1b+/ hiPSCs for 5 days.
(C and D) Immunostaining of day 10 iUB organoids derived fromWT and HNF1b+/ hiPSCs for GATA3 (green), RET (red), CK8 (white), and nuclei (blue) (C) and for
E-CADHERIN (red), PRKCz (green), and nuclei (blue) (D).
(E) qRT-PCR analysis showing the expression of PRKCz, EZRIN, LHX1, and PAX2 in WT and HNF1b+/ iUB organoids.
Data in (B) and (E) were obtained from cryopreserved UB progenitor cells; data in (C) and (D) were from non-cryopreserved UB progenitor cells. *p < 0.05 by
Student’s t test in (E). Scale bars, 100 mm.




the UB branching presented in this study and the mesenchymal-
epithelial transition of hiPSC-derived NPs previously used (Tagu-
chi et al., 2014; Takasato et al., 2015;Morizane et al., 2015). Future
studies should examine the optimal co-culture conditions.
Second, although some phenotypes, including abnormal
tubular apicobasal polarity, were successfully reproduced,
cystic structures were not found in our MCDK model (data not
shown). We assumed that our iUB organoids did not differentiate
into mature CDs that reproduce cystic lesions. Future studies
should develop induction methods, such as long-term in vitro
culture, to generate mature CDs and model the disorders that
develop CD cysts, such as MCDK, autosomal dominant polycy-
stic kidney disease (ADPKD), and autosomal recessive polycy-
stic kidney disease (ARPKD). These mature CD cells would
also contribute to analyzing the physiological functions of human
CDs, such as water and ion balance regulation after the hormon-
al stimulation of vasopressin and aldosterone.
In conclusion, we found that the acquisition of epithelial polar-
ity and tubular lumens in UB-like structures leads to the develop-
ment of branching iUB organoids in vitro. We also established a
monitoring method of tip cells utilizing DiI-VLDL uptake and a
simplified expansion method for tip cells that reconstitute
branching iUB organoids, which differentiate into CDPs. These
techniques may help elucidate the developmental mechanisms
of UB branching and develop a selective differentiation method
for CD cells, thereby contributing to the creation of CAKUT
models caused by abnormalities arising in CDs.
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REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Mouse anti-AQP2 Santa Cruz Cat#sc-515770; RRID: AB_2810957
Rabbit anti-CAII Abcam Cat#AB124687-100; RRID: AB_10972000
Mouse anti-CK8 Abcam Cat#ab9023; RRID: AB_306948
Mouse anti-E-CADHERIN BD Cat#610181; RRID: AB_397580
Mouse anti-E-CADHERIN R&D Cat#AF648; RRID: AB_355504
Mouse anti-EZRIN Abcam Cat#Ab4069; RRID: AB_304261
Mouse anti-FOXA1 Santa Cruz Cat#sc-514695
Rabbit anti-GATA3 Cell signaling Cat#5852S; RRID: AB_10835690
Goat anti-GATA3 R&D Cat#AF2605; RRID: AB_2108571
Rabbit anti-LAMININ Sigma Cat#L9393-2ML; RRID: AB_477163
Rabbit anti-PAX2 BioLegend Cat#PRB-276P; RRID: AB_291611
Goat anti-PAX2 R&D Cat#AF3364; RRID: AB_10889828
Rabbit anti-PRKCz Santa Cruz Cat#sc-216; RRID: AB_2300359
Goat anti-RET R&D Cat#AF1485; RRID: AB_354820
Mouse anti-VLDLR Santa Cruz Cat#sc-18824; RRID: AB_2216805
Donkey anti-Mouse IgG- Alexa Fluor 488 Thermo Fisher Scientific Cat#A21202; RRID: AB_141607
Donkey anti-Rabbit IgG- Alexa Fluor 488 Thermo Fisher Scientific Cat#A21206; RRID: AB_2535792
Donkey anti-Goat IgG- Alexa Fluor 488 Thermo Fisher Scientific Cat#A11055; RRID: AB_2534102
Donkey anti-Mouse IgG- Alexa Fluor 546 Thermo Fisher Scientific Cat#A10036; RRID: AB_2534012
Donkey anti-Rabbit IgG- Alexa Fluor 546 Thermo Fisher Scientific Cat#A10040; RRID: AB_2534016
Donkey anti-Goat IgG- Alexa Fluor 546 Thermo Fisher Scientific Cat#A11056; RRID: AB_2534103
Donkey anti-Mouse IgG- Alexa Fluor 647 Thermo Fisher Scientific Cat#A31571; RRID: AB_162542
Donkey anti-Rabbit IgG- Alexa Fluor 647 Thermo Fisher Scientific Cat#A31573; RRID: AB_2536183
Donkey anti-Goat IgG- Alexa Fluor 647 Thermo Fisher Scientific Cat#A21447; RRID: AB_2536183
Hoechst 33342 Thermo Fisher Scientific Cat#H1399
Chemicals, Peptides, and Recombinant Proteins
A83-01 WAKO 035-24113
Accutase Innovative Cell Technologies AT104
Activin A R&D 338-AC
Afamin/Wnt3a CM MBL J-ORMW301R
B-27 Supplement minus vitamin A Thermo Fisher Scientific 12587001
BMP4 Peprotech AF-120-05ET
bovine serum albumin Nacalai tesque 01281-84
Cell recovery solution BD 354253
CHIR99021 Stem RD CHIR-010
DAPI MERCK 10236276001
Dexamethasone Wako 047-18863
DiI-conjugated VLDL Biomedical Technologies, Inc. BT-922
DMEM/F-12, GlutaMAX Thermo Fisher Scientific 10565042
Doxycycline LTK Labs D5897
EDTA Thermo Fisher Scientific 15575020
EGF R&D 236-EG-01M
Essential 6 Medium Thermo Fisher Scientific 1516401
(Continued on next page)









Geltrex Thermo Fisher Scientific A15696-01
Hygromycin B Nacalai tesque 09287-84
iMatrix-511 silk Nippi 892021
IWR-1 MERCK I0161-5MG
LDN193189 Axon Medchem Axon1509
Matrigel BD 354230
normal donkey serum MERCK 566460
Opti-MEM I Reduced Serum Media Thermo Fisher Scientific 31985062
Puromycin Nacalai tesque 2945554
Quadrol Tokyo Chemical Industry T781
R-spondin 1 R&D 4645-RS-250
Triton X-100 Nacalai tesque 35501-15
TTNPB Santa Cruz sc-203303
Thiazovivin Santa Cruz SCB-SC-361380-10
Sucrose Nacalai tesque 30403-55
STEM-CELLBANKER GMP grade ZENOAQ RESOURCE ZR646
Stem Fit AK02N Ajinomoto AK02N
Triethanolamine Wako 145-05605
Urea Nacalai tesque 35904-45
Y-27632 Wako 034-24024
Critical Commercial Assays
In-Fusion HD cloning kit TaKaRa 639648
Lipofectamine 3000 Thermo Fisher Scientific L3000001
NEBNext Poly(A) mRNA Magnetic Isolation
Module
New England Biolabs E7490
NucleoSpin RNA XS TaKaRa 740902.5
ReverTra Ace TOYOBO TRT-101
RNeasy Mini Kit QIAGEN 74106
SMART-Seq Stranded Kit TaKaRa 634442
SYBR Premix Ex TaqII TaKaRa RR-820B
Deposited Data
Single cell RNA sequencing analysis This paper GSE152685
RNA sequencing data of DiI-VLDL(+)/(-) This paper GSE152471
RNA sequencing data of TIP and CDP This paper GSE152470
Experimental Models: Cell Lines
Human: 585A1 iPSC line ICSCB SKIP000858
Human: 1231A3 iPSC line ICSCB HPS0381
Human: 1383D2 iPSC line ICSCB HPS1005
Experimental Models: Vectors
pHL-EF1a-hcPBase-A Ishida et al., 2018 N/A
pPV-H1-gRNA-mEF1a-RiH Ishida et al., 2018 N/A
pPV-TetO-SphcCas9-iC-A-EF1a-rtTA-iP Ishida et al., 2018 N/A
Oligonucleotides
Primers for Figures 4 and S4, see Table S3 This paper N/A
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Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Kenji
Osafune (osafu@cira.kyoto-u.ac.jp).
Materials Availability
This study did not generate new unique reagents.
Data and Code Availability
The NCBI GEO accession number for RNA sequencing data reported in this paper is GSE 152470, GSE 152471 and GSE 152685.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Experiments using human induced pluripotent stem cells (hiPSCs) were approved by the Ethics Committee of the Department of
Medicine and Graduate School of Medicine, Kyoto University. Three hiPSC lines, 585A1, 1231A3 and 1383D2, were maintained
with feeder-free cultures using Stem Fit AK02N medium (Ajinomoto) on cell culture plates coated with 0.125 mg/cm2 iMatrix-511
silk (Nippi). The cells were passaged using 0.5 mM EDTA/PBS (Thermo Fisher Scientific) every four days and routinely monitored
for mycoplasma contamination.
METHOD DETAILS
Anterior intermediate mesoderm induction
hiPSCswere directed into UB lineages as described previouslywith somemodifications (Mae et al., 2018). In detail, hiPSCswere plated
at a density of 2.5 3 104 cells/cm2 in 4-well culture plates (Thermo Fisher Scientific) in Stem Fit AK02N medium with 10 mM Y-27632
(WAKO) and 0.125 mg/cm2 iMatrix-511 silk. After 24 h, the cells were washed with PBS and treated with Essential 6 medium (Thermo
Fisher Scientific) containing 100 ng/mL Activin A (R&DSystems) and 3 mMCHIR99021 (StemRD). After 16 - 24 h, the cells werewashed
with PBS and treated with Essential 6 medium containing 0.1 mMLDN193189 (AxonMedchem), 1 mMA83-01 (WAKO), 0.1 mM4-[(E)-2-
(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl]-benzoic acid (TTNPB; Santa Cruz Biotechnology) and 200 ng/mL
fibroblast growth factor (FGF) 8 (Peprotech) for 2 days. Then the cells were replated at a density of 1 3 105 cells/cm2 in Matrigel- or
Geltrex (Thermo Fisher Scientific)-coated 24-well culture plates in Essential 6 medium containing the same 4 factors and 10 mM Y-
27632 and incubated for an additional 24 h to induce anterior intermediate mesoderm (AIM).
Nephric duct induction
AIM cells were treated with Essential 6 medium containing 1 mMCHIR99021, 0.1 mM LDN193189, 200 ng/mL FGF8, 100 ng/mL glial
cell line-derived neurotrophic factor (GDNF; R&D Systems) and 0.1 mMTTNPB for 2 days to induce nephric duct (ND) leader cells. To
enhance epithelialization in 2D cultures, AIM cells were treatedwith the samemedium and inducing factors for 8 days. ND leader cells
were dissociated into single cells by pipetting after treatment with Accutase (Innovative Cell Technologies) for 3 min at 37C, seeded
onto low-attachment 96-well plates (Sumitomo Bakelite) at a density of 1 3 104 cells/well, and treated with the same medium and
factors plus 10 mM Y-27632 to induce epithelialized ND aggregates for 2 days.
iUB organoid induction
Unwanted cells were separated fromND aggregates by pipetting (Mae et al., 2018). The ND aggregates were treated with Essential 6
medium containing 1 mM CHIR99021, 0.1 mM LDN193189, 200 ng/mL FGF8, 100 ng/mL GDNF, 0.1 mM TTNPB and 2%Matrigel for
6 days to constitute iUB organoids with epithelial polarity and tubular lumens. To enhance budding, 50 ng/mL EGF (R&D Systems)
and 200 ng/mL FGF1 (R&D Systems) were added (hereafter called organoidmedium). The tips weremechanically separated from the
Continued
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iUB organoids and cultured in organoidmedium for 6 to 14 days to reconstitute branching iUB organoids. The tips separated from the
reconstituted iUB organoids were treated with organoid medium to repeatedly reconstitute iUB organoids.
ND cryopreservation
Dissociated ND leader cells were resuspended with STEM-CELLBANKER GMP grade (ZENOAQ RESOURCE) at a dilution ratio less
than 13 106 cells/mL/tube. The cell suspension was distributed to cryopreservation tubes. The tubes were frozen at 80C for 24 h
and moved to a liquid nitrogen cell storage tank for long-term cryopreservation. To initiate cultures, the cells were thawed using a
water bath at 37C. Then the cells were slowly resuspended with Essential 6 medium containing 10 mM Y-27632 and centrifuged
at 200 g for 5 min at room temperature. After removal of the supernatant, the cells were resuspended with Essential 6 medium con-
taining ND-induction factors with 10 mM Y-27632 and seeded onto low-attachment 96-well plates at a density of 1 3 104 cells/well.
Tip cell expansion
iUB organoids were treated with Accutase for 5 min at 37C and subsequently dissociated into single cells by pipetting. The cells
were resuspended with DMEM/F12, GlutaMAX medium (Thermo Fisher Scientific) containing B-27 Supplement, minus vitamin A
(Thermo Fisher Scientific), 100 ng/mL GDNF, 200 ng/mL FGF1, 0.1 mM TTNPB, 3 mM CHIR99021 and 10 mM Thiazovivin (Santa
Cruz Biotechnology). The single cells obtained from 10 iUB organoids were seeded onto one well of 48-well plates coated with
150 mL hydrogel, which is composed of DMEM/F12 medium containing 50% Matrigel and was solidified for 1 h at 37C before
use. The single cells constructed tip colonies after 6-7 days. The medium was refreshed every 2 days.
Reconstitution of iUB organoids from single tip cells
Hydrogel was dissolved with Cell Recovery Solution (BD Biosciences) for 1 h at 4C to detach day 7 tip colonies. After washing with
additional Cell Recovery Solution, the tip colonies were centrifuged at 500 g for 5 min at room temperature. Essential 6 medium con-
taining 0.1 mMLDN193189, 100 ng/mLGDNF, 0.1 mMTTNPB, 200 ng/mL FGF8, 1 mMCHIR99021 or 10%Afamin/Wnt3a conditioned
medium (MBL), 200 ng/mL R-spondin 1 (R&D systems), 50 ng/mL EGF, 200 ng/mL FGF1 and 10% Matrigel was applied to a tube
containing tip colonies. After pipetting gently with a wide-mouth micropipette (BMBio) so not to break the colonies, the suspension
was distributed to a low-attachment 35 mm dish (Sumitomo Bakelite) at 2 mL/dish. The medium was refreshed every 2 days. On day
7, 1 mM A83-01 was added to the medium and cultured for an additional 7 - 14 days.
Collecting duct progenitor induction
For 2D cultures, day 7 tip colonies detached from hydrogel were dissociated into single cells by pipetting after treatment with Accu-
tase for 3 min at 37C. The single cells were resuspended with Essential 6 medium containing 1 mM IWR-1 (Tocris) and 0.25 mg/cm2
iMatrix-511 silk with or without 1 mM A83-01 and seeded at a density of 4 3 104 cells/well in 96-well plates. For 3D cultures, day 14
reconstituted iUB organoids were treated with Essential 6 medium containing 1 mM IWR-1 and 1 mM A83-01 for 14 days.
Monitoring tip cells using DiI-VLDL
iUB organoids, tip colonies and ND aggregates were treated with 10 mg/mL DiI-conjugated VLDL (Biomedical Technologies, Inc.) for
2 h at 37C.
Flow cytometry analysis of tip cells using DiI-VLDL
iUB organoids and tip colonies treatedwith DiI-VLDLwere dissociated into single cells by pipetting after Accutase treatment for 5min
at 37C. After washing with DMEM/10% FBS, the cells were re-suspended with PBS/2% FBS. Dead cells stained with 4’, 6-Diami-
dino-2-phenylindole, dihydrochloride (DAPI; 0.1 ng/ml; Thermo Fisher Scientific) were excluded from the analysis. Single cells were
analyzed and sorted using FACSAria II (BD). Cells derived from iUB organoids and tip colonies without DiI-VLDL treatment were used
as negative controls for gating.
RNA sequencing analysis
Day 6 iUB organoids were treated with DiI-VLDL for 2 h and dissociated into single cells by pipetting after treatment with Accutase for
3 min at 37C. Then flow cytometry analysis was performed to sort DiI-VLDL+ and DiI-VLDL- cells. The total RNA of sorted DiI-VLDL+
andDiI-VLDL- cells was isolated using a NucleoSpinRNAXS (TaKaRa). To analyze CDPs and TIP cells, day 10CDPs and day 6 TIP cells
were dissociated into single cells by pipetting after treatment with Accutase for 3min at 37C. The total RNA of each single cell was iso-
lated using an RNeasy Mini Kit (QIAGEN). The samples were preserved at80C, and RNA sequence library preparation, sequencing,
mapping, geneexpression, andgeneontology (GO)enrichmentanalysiswereperformedbyDNAFORM(Yokohama,Kanagawa, Japan).
The quality of total RNAwas assessed by using a Bioanalyzer (Agilent) to ensure that RIN (RNA integrity number) was over 7.0. After
poly (A) + RNA enrichment by using a NEBNext Poly (A) mRNA Magnetic Isolation Module (New England BioLabs), double-stranded
cDNA libraries (RNA-seq libraries) were prepared using a SMART Seq Stranded Kit (TaKaRa) according to the manufacturer’s
instructions. RNA-seq libraries were sequenced using paired end reads (50 nt of read 1 and 25 nt of read 2) on a NextSeq 500
instrument (Illumina). Obtained reads weremapped to the humanGRCh38 genome using STAR (version 2.7.2b). Reads on annotated
genes were counted using featureCounts (version 1.6.1).




Single cell RNA sequencing analysis
Dissociated day 6 iUB cells were resuspended in PBS containing 1% BSA and immediately followed by library preparation targeting
5,000 cells using the Chromium Single Cell 30 Reagent Kit v3 (103Genomics) and the ChromiumController (103Genomics) accord-
ing to manufacturer’s instructions. The library was sequenced on a HiSeq2500 TruSeq SBS v3 reagent.
Generation of heterozygous HNF1b knockout hiPSCs
We established the heterozygous HNF1b knockout hiPSC line using the CRONUS system (Ishida., et al., 2018). To generate CRONUS
hiPSC lines, 1 3 106 1231A3 cells were resuspended in 100 mL of Opti-MEM (Thermo Fisher Scientific) with piggyBac vectors
(pPV-TetO-SphcCas9-iC-A-EF1a-rtTA-iP: 2 mg, pPV-H1-gRNA-mEF1a-RiH: 2 mg) and a piggyback transpose vector (pHL-EF1a-hcP-
Base-A: 2 mg). The gRNA specifically recognizing the HNF1b sequence was designed as shown in Figure 4A, and pPV-H1-gRNA-mE-
F1a-RiH was established using an In-Fusion HD Cloning Kit (TaKaRa). Cells were transfected with these vectors using Lipofectamine
3000 (Thermo Fisher Scientific). After lipofection, the cells were plated onto one well of a 6-well iMatrix-511 silk-coated plate in StemFit
AK02N medium with 10 mM Y-27632. From the following day, the cells were treated with 1 mg/mL Puromycin (Nacalai tesque) and
200 mg/mL Hygromycin B (Nacalai tesque) for drug selection for 5 days. The expression of mRFP1 protein indicated gRNA expression.
Wepicked upmRFP1-positive colonies and expanded them to obtainCRONUS1231A3 cell lines. Then the cells were treatedwith 2 mM
Dexamethasone (Wako) and 1 mMDoxycycline (LTKLabs) to induce the expressionofCas9protein and traffic the protein to the nucleus.
HNF1b mutations were confirmed using Sanger sequencing analysis. The primer sequences used are shown in Table S3.
Real-time PCR analysis
Total RNAs isolated using the RNeasy Mini Kit (QIAGEN) were reverse-transcribed with ReverTra Ace (TOYOBO) according to the
manufacturers instructions. Real-time PCR analysis was performed with SYBR Premix Ex TaqII (TaKaRa). The expression of each
gene was normalized to the level of bACTIN expression. The primer sequences used are shown in Table S3.
Immunostaining
Immunostaining analysis was performed as described previously with some modifications (Mae et al., 2018). For 2D cultures, the
cells were fixed with 4% paraformaldehyde (PFA)/PBS for 20 min at 4C. After washing with PBS twice, the cells were blocked
with 1% normal donkey serum (MERCK) and 3% bovine serum albumin (BSA; Nacalai tesque)/PBT (PBS/0.25% Triton X-100, Na-
calai tesque) for 1 h at room temperature. Primary antibodies were diluted with blocking solution at 1:500 and incubated with the
samples overnight at 4C. After washing with PBT twice, secondary antibodies diluted with blocking solution at 1:500 were incubated
for 1 h at room temperature.
For the immunostaining analysis of frozen sections, samples were fixed with 4% PFA/PBS for 1 h at 4C. Fixed samples were
treated with 30% sucrose (Nacalai tesque)/PBS and frozen with OCT compound (Tissue-Tek) to make frozen sections by cryosec-
tioning. The frozen sections were washed with distilled water and incubated with blocking solution for 1 h at room temperature. Pri-
mary antibodies except for PRKCz were diluted with blocking solution at 1:500 and incubated with the samples overnight at room
temperature. PRKCz antibody was diluted at 1:50. After washing with distilled water twice, the sections were incubated with second-
ary antibodies diluted with blocking solution at 1:500 for 1 h at room temperature. Fluorescence images were captured by a BZ-X700
(KEYENCE). Image analysis was performed using a BZ-X Analyzer (KEYENCE).
For 3D imaging analysis, we applied Clear, UnobstructedBrain/Body ImagingCocktails andComputational analysis (CUBIC) (Nojima
et al., 2017; Susaki et al., 2015). After fixation with 4%PFA/PBS for 24 h at 4C, the samples were treated with CUBIC1 solution diluted
with distilledwater at a 1:2 ratio on a seesaw shaker set at 30 rpm for 8 h at room temperature for tissue clearing. Then the sampleswere
treated with CUBIC1 solution on the seesaw shaker at 30 rpm for 24 h at room temperature. After washing with PBS, the samples were
incubatedwithblockingsolutionon theseesawshakerat30 rpm for2hat4C.Primaryantibodiesweredilutedwithblockingsolutionand
incubatedwith the samples on the seesawshaker at 30 rpm for 24 h at 4C. After washingwith blocking solution, the sampleswere incu-
batedwith secondary antibodieson the seesawshaker at 30 rpm for 24hat 4C.AfterwashingwithPBS twice, the sampleswere treated
withCUBIC2 solution dilutedwith PBS at a 1:2 ratio on the seesawshaker at 30 rpm for 8 h at room temperature. Then the sampleswere
treatedwithCUBIC2 solution on the seesawshaker at 30 rpm for 24 h at room temperature and fluorescence imageswere capturedbya
ZeissLSM710 (Zeiss).Details of theantibodiesused in this studyare shown inKeyResourcesTable. Imageanalysiswasperformedusing
ZEN 2 blue edition (Zeiss). CUBIC1 solution is a mixture of urea (10% final concentration, Nacalai tesque), Quadrol (25% final concen-
tration,TokyoChemical Industry), TritonX-100 (5%finalconcentration), 5MNaClanddistilledwater.CUBIC2solution isamixtureofurea
(25% final concentration), sucrose (50% final concentration), triethanolamine (10% final concentration, Wako) and distilled water.
QUANTIFICATION AND STATISTICAL ANALYSIS
RNA sequencing data processing
FPKM values were calculated frommapped reads by normalizing to total counts and transcripts. Differentially expressed genes were
detected using the DESeq2 package (version 1.20.0). The list of differentially expressed genes detected by DESeq2 (basemean > 5
and fold-change < 0.25, or basemean > 5 and fold-change > 4) were used for GO enrichment analysis by the clusterProfiler package
(Yu et al., 2012).




Single cell RNA sequencing data processing
The deconvolution of UMIs and cell barcodes of BCL files were conducted using bcl2fastq 2.20.0.422 and resulted in cell-specific
FASTQ files (Illumina). Alignment to the human reference genome GRCh38 and UMI counting were conducted using the Cell Ranger
v3.1.0 pipeline (103Genomics). Dimensionality reduction was carried out using the UniformManifold Approximation and Projection
(UMAP) algorithm, and the cell clusters were visualized using Seurat package v3.1.1. Genes with adjusted P-values < 0.05 and fold-
changeR 2.0 in the Tukey-Kramer test were considered as differentially expressed genes (DEGs) and used in the signal pathway
analysis using Ingenuity Pathway Analysis software (QIAGEN). Heatmaps were generated using the pheatmap function of R package
v3.6.1.
Statistical analysis
Data of the flow cytometry and cell count analyses are presented as the mean ± SE, and the statistical analyses were performed on
EZR (Kanda, 2013). Statistical analysis for the difference between two groups was performed using Student’s t test. Differences were
considered significant when p < 0.05.
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